Concepedia

Publication | Closed Access

LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial

63

Citations

0

References

2020

Year

No additional data available for this publication yet. Check back later!